SynthesisBiomolecules2025

Divergent Risks of Hematologic Malignancies Associated with GLP-1 Receptor Agonists and SGLT2 Inhibitors: Preliminary Findings from a Pilot Network Meta-Analysis.

Pao-Yen Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.